Cargando…

Ursolic acid restores sensitivity to gemcitabine through the RAGE/NF-κB/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model

Gemcitabine (GEM) is a first-line drug for pancreatic cancer therapy, but GEM resistance is easily developed in patients. Growing evidence suggests that cancer chemoprevention and suppression are highly associated with dietary phytochemical and microbiota composition. Ursolic acid (UA) has anti-infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zih-Ying, Chen, Sheng-Yi, Weng, Ming-Hong, Yen, Gow-Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Food and Drug Administration 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261828/ https://www.ncbi.nlm.nih.gov/pubmed/35696208 http://dx.doi.org/10.38212/2224-6614.3346

Ejemplares similares

4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine-resistant pancreatic cancer cells
por: Chen, Ying-Yin, et al.
Publicado: (2022)

miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer
por: Wang, Hui, et al.
Publicado: (2017)

Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells
por: Lan, Chieh-Yu, et al.
Publicado: (2019)

Not only a bad guy: potential proneurogenic role of the RAGE/NF-κB axis in Alzheimer's disease brain
por: Bortolotto, Valeria, et al.
Publicado: (2016)

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
por: Inkoom, Andriana, et al.
Publicado: (2020)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)

Antifibrotic effects of pentoxifylline improve the efficacy of gemcitabine in human pancreatic tumor xenografts
por: Kim, Jung Ho, et al.
Publicado: (2017)

Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
por: Miller, Aubrey L., et al.
Publicado: (2020)

Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression
por: Guo, Hongchun, et al.
Publicado: (2020)

d-ribose induces nephropathy through RAGE-dependent NF-κB inflammation
por: Hong, Jinni, et al.
Publicado: (2018)

Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro
por: Kong, Lei, et al.
Publicado: (2022)

Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
por: Inkoom, Andriana, et al.
Publicado: (2023)

Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-κB, AP-1 and NF-AT
por: Checker, Rahul, et al.
Publicado: (2012)

Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
por: Yu, Chao, et al.
Publicado: (2018)

Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF-κB Pathway in Gastric Cancer Cells
por: Li, Jinxia, et al.
Publicado: (2019)

Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment
por: Prasad, Sahdeo, et al.
Publicado: (2016)

RAGE Plays a Role in LPS-Induced NF-κB Activation and Endothelial Hyperpermeability
por: Wang, Liqun, et al.
Publicado: (2017)

A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
por: Matsumoto, Takeshi, et al.
Publicado: (2021)

PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB
por: Rodriguez, M, et al.
Publicado: (2014)

Ursolic Acid Attenuates Atherosclerosis in ApoE(−/−) Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway
por: Li, Qiu, et al.
Publicado: (2018)

Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
por: Panebianco, Concetta, et al.
Publicado: (2021)

Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model
por: Yehya, Ashwaq Hamid Salem, et al.
Publicado: (2022)

Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
por: Liu, Jiangbo, et al.
Publicado: (2014)

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
por: Tong, Hongfei, et al.
Publicado: (2020)

Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function
por: Dorenkamp, Marc, et al.
Publicado: (2023)

The S100B/RAGE Axis in Alzheimer's Disease
por: Leclerc, Estelle, et al.
Publicado: (2010)

The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
por: Reynaert, Niki L., et al.
Publicado: (2023)

RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB
por: Cataldegirmen, Guellue, et al.
Publicado: (2005)

Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro
por: Ding, Bo, et al.
Publicado: (2020)

Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathways
por: Su, Sheng-Chiang, et al.
Publicado: (2019)

Diesel Particulate Matter Induces Receptor for Advanced Glycation End-Products (RAGE) Expression in Pulmonary Epithelial Cells, and RAGE Signaling Influences NF-κB–Mediated Inflammation
por: Reynolds, Paul R., et al.
Publicado: (2011)

Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
por: Panebianco, Concetta, et al.
Publicado: (2021)

The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
por: Jia, Yanfei, et al.
Publicado: (2018)

Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma
por: Chen, Dong, et al.
Publicado: (2012)

Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer
por: Jung, H, et al.
Publicado: (2015)

Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro
por: Banerjee, Jheelam, et al.
Publicado: (2014)

Ursolic Acid Alleviates Neuroinflammation after Intracerebral Hemorrhage by Mediating Microglial Pyroptosis via the NF-κB/NLRP3/GSDMD Pathway
por: Lei, Pan, et al.
Publicado: (2023)

Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways
por: Zou, Chongchong, et al.
Publicado: (2022)

The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis
por: Stock, Amanda J., et al.
Publicado: (2016)

The Immune Tolerance Role of the HMGB1-RAGE Axis
por: Watanabe, Haruki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h7rnkkdu18e2o113uf8bn1cfv0